Home

Students Den

ITHyderabad

BizHyderabad

Movie Review

Reachout's  Newsmaker

Dr.Pavan Reddy, M.D.
One of the youngest Indians to receive the Alaina J Enlow Scholar Award

 

Hyderabad, Nov'05: Continuing the legacy of the young Connecticut woman who wanted to improve the lives of marrow and blood cell transplant patients, The Marrow Foundation® and the National Marrow Donor Program® (NMDP) have announced the 2005 Amy Strelzer Manasevit Research Program for the Study of Post-Transplant Complications award winners.
One of the youngest recipient is Hyderabad born Dr.Pavan R. Reddy, who was designated the 2005 Alaina J. Enlow Scholar. Reddy’s research focuses on allogeneic hematopoietic stem cell post-transplant complications, and his study is titled: “Regulation of Acute Graft-versus-Host Disease and Graft-versus-Leukemia Effect by Histone Deacetylase Inhibitors.” 

Dr. Reddy will investigate the use of a new class of agents that could potentially alleviate some complications associated with Graft-versus-Host Disease (GVHD) and make allogeneic hematopoietic cell transplantation safer.

Alaina, a charismatic and gifted young photographer, succumbed to post-transplant complications caused by graft-versus-host disease (GVHD) following her second transplant when she was 18. “Alaina always liked the idea that doctors could learn from her experiences, and we are humbled that her ultimate sacrifice will someday lead to major breakthroughs in transplant and
post-transplant care,” said her father, John Enlow of Denton, Tex.

Dr. Pavan Reddy received a medical degree from Osmania University, India. He then continued his training at the University of Michigan where he completed a three-year residency in internal medicine, a hematology/oncology fellowship and a one-year fellowship in blood and marrow transplantation. Following the completion of his fellowship, he joined the faculty of
the University of Michigan in 2002. Dr. Reddy's research interests focus on understanding the immunobiology of graft-versus-host disease (GVHD) in the laboratory and translating the insights gained into improved treatments for patients with GVHD.

- Nov' 2005

More Newsmakers...

This site is conceived, designed, and maintained by Reach-out Business Network.
 All rights reserved world wide. Copyright © 1999- 2005. Mail your queries to reachouthyderabad@yahoo.com
Disclaimer:
Neither Reachout Business Network, nor the sources it  obtained the information from, are responsible for the correctness/validity of the information in these pages. It is a collection of both facts and opinions. You are advised to verify all information with a reliable source before acting on it. This disclaimer applies to all pages of ReachoutHyderabad.com.
Reproduction in whole or in part in any form or medium without written permission of ReachoutHyderabad is prohibited.